A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.
Clinical trial NCT02576548 · COMPLETED
Trial details
- NCT number
- NCT02576548
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-23
- Primary completion
- 2018-05-23
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.